Lineage Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Lineage Cell Therapeutics
LCTX Stock  USD 0.50  0.0009  0.18%   
Lineage Cell financial statements provide useful quarterly and yearly information to potential Lineage Cell Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Lineage Cell financial statements helps investors assess Lineage Cell's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Lineage Cell's valuation are summarized below:
Gross Profit
-3.3 M
Profit Margin
(1.96)
Market Capitalization
118.7 M
Enterprise Value Revenue
7.7328
Revenue
9.5 M
We have found one hundred twenty available fundamental ratios for Lineage Cell, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Lineage Cell last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 61 M in 2025, whereas Market Cap is likely to drop slightly above 67.4 M in 2025.

Lineage Cell Total Revenue

9.97 Million

Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 10 M, as well as many indicators such as Price To Sales Ratio of 10.06, Dividend Yield of 0.0015 or PTB Ratio of 1.37. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
  
Check out the analysis of Lineage Cell Correlation against competitors.

Lineage Cell Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets118.9 M113.2 M99.4 M
Slightly volatile
Total Current Liabilities14.7 M14 M11.5 M
Slightly volatile
Total Stockholder Equity80.9 M77 M68.2 M
Slightly volatile
Accounts Payable2.1 M1.2 M3.5 M
Pretty Stable
Cash48.1 M45.8 M26.8 M
Slightly volatile
Cash And Short Term Investments50.2 M47.8 M32.7 M
Slightly volatile
Common Stock Shares Outstanding210.2 M200.2 M115.9 M
Slightly volatile
Liabilities And Stockholders Equity118.9 M113.2 M99.4 M
Slightly volatile
Non Current Liabilities Total23.3 M22.2 M11.1 M
Slightly volatile
Total Liabilities38 M36.2 M22.6 M
Slightly volatile
Total Current Assets53.5 M51 M40.3 M
Slightly volatile
Property Plant And Equipment Net2.3 M4.4 M4.3 M
Slightly volatile
Non Current Assets Total65.3 M62.2 M59 M
Slightly volatile
Other Current Assets1.4 M2.6 M2.1 M
Pretty Stable
Property Plant And Equipment Gross9.2 M8.8 M6.2 M
Slightly volatile
Inventory0.860.947 K
Slightly volatile
Other Current Liabilities3.7 M3.1 M5.2 M
Pretty Stable
Common Stock Total Equity531.6 M506.3 M322.8 M
Slightly volatile
Common Stock509 M484.7 M320.4 M
Slightly volatile
Short and Long Term Debt Total3 M2.5 M2.5 M
Slightly volatile
Current Deferred Revenue7.8 M7.4 M3.7 M
Slightly volatile
Short Term Debt1.4 M2.3 M1.3 M
Very volatile
Intangible Assets34.9 M46.5 M31.9 M
Slightly volatile
Capital Surpluse6.1 K6.4 K28.7 K
Slightly volatile
Deferred Long Term Liabilities36 M34.3 M13.7 M
Slightly volatile
Non Current Liabilities Other3.6 M3.4 M1.5 M
Slightly volatile
Property Plant Equipment6 M6.5 M5.1 M
Slightly volatile
Long Term Debt15.4 K16.2 K520.4 K
Slightly volatile
Net Receivables606.1 K638 K5.9 M
Pretty Stable
Long Term Debt Total65.8 K69.3 K844.5 K
Pretty Stable
Preferred Stock Total Equity2.8 M3.1 M3.4 M
Slightly volatile
Other Liabilities36 M34.3 M11.1 M
Slightly volatile
Short Term Investments1.9 M2 M6.1 M
Slightly volatile
Short and Long Term Debt283.5 K470.7 K318.3 K
Slightly volatile
Capital Lease Obligations3.2 M2.5 M2.5 M
Slightly volatile
Net Invested Capital77.4 M78.4 M124.4 M
Slightly volatile
Net Working Capital31.5 M37 M37.3 M
Very volatile
Capital Stock463 M484.7 M390.2 M
Slightly volatile
Good Will8.5 M9.6 M10.5 M
Slightly volatile

Lineage Cell Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue10 M9.5 M4.3 M
Slightly volatile
Other Operating Expenses21.1 M31 M37.7 M
Very volatile
Cost Of Revenue570.7 K334 K585 K
Very volatile
Total Operating Expenses21.4 M30.6 M37.2 M
Very volatile
Research Development12.9 M12.5 M21.2 M
Pretty Stable
Selling General Administrative11.3 M18.2 M17.7 M
Slightly volatile
Interest Income1.6 M1.7 M13.1 M
Very volatile
Reconciled Depreciation578.5 K609 K2.4 M
Slightly volatile
Non Recurring640 K720 K785 K
Slightly volatile
Selling And Marketing Expenses449.6 K505.8 K551.5 K
Slightly volatile

Lineage Cell Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow37.8 M36 M25.4 M
Slightly volatile
Total Cash From Financing Activities37.6 M35.9 M26 M
Very volatile
End Period Cash Flow48.7 M46.4 M27.2 M
Slightly volatile
Depreciation578.5 K609 K2.7 M
Slightly volatile
Stock Based Compensation3.5 M5.1 M4.1 M
Pretty Stable
Dividends Paid31.6 K33.3 K4.4 M
Pretty Stable
Issuance Of Capital Stock37.7 M35.9 M10.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.0610.590397.8762
Pretty Stable
Dividend Yield0.00150.00160.1682
Slightly volatile
PTB Ratio1.371.30635.1781
Slightly volatile
Book Value Per Share0.410.38470.767
Slightly volatile
Average Payables897.5 K1.6 M1.9 M
Pretty Stable
Stock Based Compensation To Revenue0.510.53451.6818
Pretty Stable
Capex To Depreciation1.061.120.6864
Very volatile
PB Ratio1.371.30635.1781
Slightly volatile
EV To Sales5.736.034585.5421
Pretty Stable
Inventory Turnover5.653.624.2952
Slightly volatile
Days Of Inventory On Hand5.0E-46.0E-421.1313
Slightly volatile
Sales General And Administrative To Revenue1.821.91297.8455
Very volatile
Average Inventory0.40.450.4906
Slightly volatile
Research And Ddevelopement To Revenue1.251.3139.4501
Slightly volatile
Capex To Revenue0.06440.06780.5408
Pretty Stable
Cash Per Share0.330.23880.3529
Slightly volatile
Days Payables Outstanding7461.3 K1.4 K
Pretty Stable
Intangibles To Total Assets0.440.50530.4068
Very volatile
Net Debt To EBITDA2.122.01491.0498
Very volatile
Current Ratio5.313.64864.7682
Slightly volatile
Shareholders Equity Per Share0.340.38470.6262
Pretty Stable
Capex Per Share0.00330.00350.015
Slightly volatile
Revenue Per Share0.030.04740.0357
Very volatile
Interest Debt Per Share0.01190.01260.0671
Slightly volatile
Debt To Assets0.02110.02220.0765
Slightly volatile
Graham Number2.462.763.0098
Slightly volatile
Price Book Value Ratio1.371.30635.1781
Slightly volatile
Days Of Payables Outstanding7461.3 K1.4 K
Pretty Stable
Company Equity Multiplier1.541.47011.8122
Slightly volatile
Long Term Debt To Capitalization0.0190.020.0775
Slightly volatile
Total Debt To Capitalization0.030.03160.1004
Slightly volatile
Quick Ratio5.33.64864.7618
Slightly volatile
Net Income Per E B T1.221.00150.9626
Very volatile
Cash Ratio4.273.2763.498
Slightly volatile
Days Of Inventory Outstanding5.0E-46.0E-421.1313
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.141.181.0341
Pretty Stable
Price To Book Ratio1.371.30635.1781
Slightly volatile
Fixed Asset Turnover2.052.16131.1706
Pretty Stable
Debt Ratio0.02110.02220.0765
Slightly volatile
Price Sales Ratio10.0610.590397.8762
Pretty Stable
Asset Turnover0.07970.08390.0455
Slightly volatile
Gross Profit Margin0.980.96480.7882
Pretty Stable
Price Fair Value1.371.30635.1781
Slightly volatile

Lineage Cell Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap67.4 M90.5 M124.9 M
Slightly volatile
Enterprise Value61 M51.6 M92.2 M
Slightly volatile

Lineage Fundamental Market Drivers

Cash And Short Term Investments47.8 M

Lineage Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Lineage Cell Financial Statements

Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue7.4 M7.8 M
Total Revenue9.5 M10 M
Cost Of Revenue334 K570.7 K
Stock Based Compensation To Revenue 0.53  0.51 
Sales General And Administrative To Revenue 1.91  1.82 
Research And Ddevelopement To Revenue 1.31  1.25 
Capex To Revenue 0.07  0.06 
Revenue Per Share 0.05  0.03 
Ebit Per Revenue(2.26)(2.37)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY